Clinical Trials · NCT06557811

Effect of Oral Semaglutide on Epicardial and Pericoronary Adipose Tissues in Type 2 Diabetes After Myocardial Infarction

UnknownPhase 4Semaglutide (Unclear)
Phase
Phase 4
Recruitment status
Unknown
Sponsor
University of Sao Paulo General Hospital
Enrollment
88
Start date
Sep 2024
Locations
1 site, Brazil
Primary endpoint
Measurement of pericardial adipose tissue at 180 days
View Semaglutide compound reference